A61K 45 - Medicinal preparations containing active ingredients not provided for in groups

Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
11/2006
11/08/2006	EP1718265A2 Canine probiotic bifidobacteria globosum
11/08/2006	EP1718168A1 Composition for the treatment of chronic venous insufficiencies comprising an extract of red vine leaves and an anti-inflammatory agent
11/08/2006	EP1718155A2 Methods of use of probiotic bifidobacteria for companion animals
11/08/2006	EP1718154A2 Canine probiotic lactobacilli
11/08/2006	EP1539742B1 Indole derivatives useful as histamine h3 antagonists
11/08/2006	EP1337269B1 Association of calpain inhibitors and reactive oxygen species trapping agents
11/08/2006	EP1296716B1 Use of a beta-blocker for the treatment of atherosclerosis
11/08/2006	EP1278518B1 Synergistic combination for the treatment of colorectal cancer
11/08/2006	EP1265920B1 Angiogenesis-associated proteins, and nucleic acids encoding the same
11/08/2006	EP1225878B1 Rar-gamma selective retinoid agonists for the treatment of emphysema
11/08/2006	EP1073436B1 Improved method for eradication of helicobacter pylori
11/08/2006	EP0934069B1 Method and composition for the treatment of lipid and glucose metabolism disorders
11/08/2006	CN1860129A Novel peptide ligands of leukocyte integrins
11/08/2006	CN1859924A Pharmaceutical composition comprising a selective i1 imidazoline receptor agonist and an angiotensin ii receptor blocker
11/08/2006	CN1859918A Methods for treating acute and overuse sprain and strain using hyaluronic acid
11/08/2006	CN1859913A Method of improved diuresis in individuals with impaired renal function
11/08/2006	CN1859911A A pharmaceutical composition comprising a P2X7 receptor antagonist and a nonsteroidal anti inflammatory drug
11/08/2006	CN1859901A Oral antidepresant formation comprising acetylsalicyclic acid to accelerate onset of action
11/08/2006	CN1857726A Medicine composition for treating hypertension complicated with hyperlipemia and cardiac and cerebral vascular diseases
11/08/2006	CN1857725A Slow released compound antituberculotic preparation containing synergist
11/08/2006	CN1857724A Slow released preparation containing antituberculotic
11/08/2006	CN1857723A Slow released anticancer medicine preparation with both amrubicin and its synergist
11/08/2006	CN1857280A Slow released compound antituberculotic preparation
11/08/2006	CN1857229A Medicine dragee suitable for children to take and its preparing method
11/08/2006	CN1857221A Slow released anticancer medicien containing both platinum compound and its synergist
11/08/2006	CN1857220A Slow released antituberculotic preparation
11/08/2006	CN1857219A Slow released medicine prepn containing antituberculotic
11/08/2006	CN1857218A Slow released medicine containing antituberculotic
11/08/2006	CN1857217A Slow released anticancer injection containing estrogen receptor antagonist
11/08/2006	CN1857216A Slow released injection containing satraplatin and its synergist
11/08/2006	CN1857215A Slow released injection containing antimetabolite
11/08/2006	CN1857214A Slow released anticancer injection with both antimetabolite and cellular poison medicine
11/08/2006	CN1857213A Slow released anticancer injection with both antimetabolite and cellular poison medicine
11/08/2006	CN1857212A Slow released anticancer injection containing antimetabolite and cellular poison medicine
11/08/2006	CN1857211A Slow released injection containing Nolatrexed and its synergist
11/08/2006	CN1857210A Slow released anticancer medicine with both antimetabolite and its synergist
11/08/2006	CN1857209A Slow released anticancer injection containing antimetabolite
11/08/2006	CN1857208A Slow released anticancer injection with both antimetabolite and its synergist
11/08/2006	CN1857207A Slow released compound anticancer injection containing blood vessel inhibitor
11/08/2006	CN1857206A Slow released anticancer injection containing blood vessel inhibitor
11/08/2006	CN1857205A Slow released injection containing blood vessel inhibitor and its synergist
11/08/2006	CN1857204A Slow released anticancer medicine with both blood vessel inhibitor and its synergist
11/08/2006	CN1857203A Slow released compound anticancer injection containing blood vessel inhibitor
11/08/2006	CN1857202A Slow released anticancer injection with blood vessel inhibitor and cellular poison medicine
11/08/2006	CN1857201A Slow released anticancer injection with both blood vessel inhibitor and its synergist
11/08/2006	CN1283805C Feeding assay for identifying nematicidal compounds
11/08/2006	CN1283318C Medicinal preparation of slowly-released bioactive substance, its prepn. and application
11/08/2006	CN1283317C Use of opioid kappa receptor-excited compound in preparing pharmaceuticals for treating septicemia
11/08/2006	CN1283313C Use of alpha-helix apolipoprotein or HDL-related protein in preparing drugs for prevention and treatment of restenosis by local administration
11/08/2006	CN1283255C Magnetic slow release 5-aminosalicylic acid with intercalate structure and its preparation method
11/08/2006	CN1283248C Combinations comprising epothilones and pharmaceutical uses thereof
11/07/2006	US7133814 System and methods for optimized drug delivery and progression of diseased and normal cells
11/07/2006	US7132553 Inhibitor is a (2-amino-(optionally -1-oxo)-3-thiopropyl)--5,6,7,8-tetrahydroimidazo[1,2a]pyrazine derivative or its disulfide dimer, e.g., (2-amino-1-oxo-3-thiopropyl)-8-(cyclohexylmethyl)-2-phenyl-5,6,7,8-tetrahydroimidazo[1,2a]pyrazine
11/07/2006	US7132511 Modified anti-EGFR antibodies with reduced immunogenicity
11/07/2006	US7132441 Administering therapeutically-effective amount of a 5-lipoxygenase inhibitor and a cyclooxygenase-2 inhibitor selected from Dupont Dup 697, Taisho NS-398, meloxicam, flosulide and heterocyclic compounds
11/07/2006	US7132438 Benzimidazole derivatives
11/07/2006	US7132435 Syn-1H-indazole-3-carboxylic acid (4-{[2-(2,3-dihydro-benzo[b]thiophen-6-yloxy)-5-fluoro-pyridine-3-carbonyl]amino}-cyclohexyl)-amide; useful as cyclic nucleotide phosphodiesterase-4 ( PDE-4 ) inhibitor
11/07/2006	US7132430 Treatment of cardiovascular and related pathologies
11/07/2006	US7132415 Especially a substituted azetidinone compound
11/07/2006	US7132408 Composition and method for inhibiting platelet aggregation
11/07/2006	US7132396 Compositions which can be used for regulating the activity of parkin
11/07/2006	US7132279 Epidermal melanocyte culture formulations
11/07/2006	US7132261 Nuclear localization peptides for estrogens; antitumor agents; anticarcinogenic agents; hormone replacement therapy; bradycardial agents
11/07/2006	US7132255 drug screening for compounds that enhance or suppress killer T cell activity by contacting a population of killer T cells which express biliary glycoprotein with a compound that binds biliary glycoprotein and determining the cytotoxicity or proliferation of the killer T cells relative to a control
11/07/2006	US7132248 Uses of galanin GALR2 receptors
11/07/2006	US7132232 Diagnosing mammary gland cancer; obtain mammary gland fluid, detect preferential virus in fluid, evaluate for cancer
11/07/2006	US7132116 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds
11/07/2006	US7132112 Mixture with alcohol carrier; administering to drug nose mucous membrane; side effect reduction
11/07/2006	US7132111 reacting guaiacol and phenol with sulfuric acid and water to make a preselected concentration of preselected isomers of phenolsulfonic acid and guaiacolsulfonic acid; treating periodontal disease and canker sores; exfoliants for feet and faces.
11/07/2006	US7132108 Immunizing poultry from infection from Salmonella enteritidis by administering a total dose of killed S. enteritidis of 0.15 to 15 mg, administered as a single dose, of a suspension of microspheres comprising killed S. enteritidis encapsulated in porous poly(lactide-coglycolide) copolymer shell
11/07/2006	US7132102 Bacteriocin isolated from Lactobacillus salivarius deposited with United States Department of Agricultural, Agricultural Research Service Patent Culture Collection as Accession Number NRRL-B30514; used for reducing the levels of colonization by a target bacteria in animals, especially poultry
11/07/2006	US7131994 Muscle-based grafts/implants
11/07/2006	CA2416879C Methods of treating cancer and the pain associated therewith using endothelin antagonists
11/07/2006	CA2281755C Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
11/07/2006	CA2277824C Dosage composition for nasal delivery and method of use of the same
11/07/2006	CA2260943C Formulation of 5-ht agonists
11/02/2006	WO2006116470A1 Use of metformin to counteract weight gain associated with aripiprazole or ziprasidone treatment
11/02/2006	WO2006116262A1 Use of vitamin e tocotrienols for the inhibition of intracellularly obligate pathogen chlamydia
11/02/2006	WO2006116221A2 Therapeutic combinations for the treatment or prevention of psychotic disorders
11/02/2006	WO2006115509A2 Small molecule immunopotentiators and assays for their detection
11/02/2006	WO2006115304A1 Agent for treating neuropathic pain
11/02/2006	WO2006115302A1 Therapeutic agent for neuropathic pain
11/02/2006	WO2006115297A1 Method for evaluating compound using barlp and substance for suppressing eating and body weight
11/02/2006	WO2006115295A1 Compositions and methods for treating hemostasis disorders associated with clec-2 signal transduction
11/02/2006	WO2006115285A1 Pharmaceutical composition
11/02/2006	WO2006115193A1 Remedy for xanthoma
11/02/2006	WO2006115140A1 Preventive or remedy for bowel disease
11/02/2006	WO2006115137A1 2-aminobenzimidazole derivative and use of the same for medical purposes
11/02/2006	WO2006115135A1 Therapeutic agent for irritable bowel syndrome
11/02/2006	WO2006115115A1 Combined pharmaceutical preparation for treatment of type 2 diabetes
11/02/2006	WO2006114001A1 Method for improving pharmacokinetics of protease inhibitors and protease inhibitor precursors
11/02/2006	WO2006113993A1 MATRIX METALLOPROTEINASE INHIBITORS OF TGFß -INDUCED SUBCAPSULAR CATARACT FORMATION
11/02/2006	WO2006086500A3 Compositions and methods for treating vascular, autoimmune and inflammatory diseases
11/02/2006	WO2006077592A3 Therapeutic transplantation using developing, human or porcine, renal or hepatic, grafts
11/02/2006	WO2005117872A3 Dual acting snri-nmda antagonists for the treatment of genitourinary disorders
11/02/2006	WO2005092442B1 Method and compositions for treatment of chronic neuropathic pain
11/02/2006	WO2005092385A3 Combination therapy of azd2171 and a taxane
11/02/2006	WO2005092384A3 Combination therapy with azd2171 and a platinum anti-tumour agent
11/02/2006	WO2005092303A3 Combination therapy with azd2171 and 5-fu and/or cpt-11
11/02/2006	WO2005070080A3 Methods of using zonisamide as an adjunctive therapy for partial seizures

1 ... 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 ... 1151